Friday 6 November 2026 Export AMRX’s income statement to Excel — free account

AMNEAL PHARMACEUTICALS, INC.

AMRX Healthcare Drug Manufacturers Specialty & Generic

AMNEAL PHARMACEUTICALS, INC.’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, up 8.05% from fiscal 2024.

Revenue: +9.96%
EPS: +267.0%
Free cash flow: −50.9%
Total debt: +23.8%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

20.23 0.78 +4.01%

Follow AMRX

Alert me

Market cap: $6.8B
P/E: 36.9×
Fwd P/E: 44.2×
Dividend yield: —
F-score: 7/9
Altman Z: 1.94
Beneish M: −2.68
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

AMNEAL PHARMACEUTICALS, INC. (AMRX) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, AMNEAL PHARMACEUTICALS, INC. (AMRX) trades at a P/E ratio of 36.9×. Over the past ten years it has ranged from 0.0× (June 2025) to 1,009× (September 2025); the current reading is higher than 77% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 20.5× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/AMRX/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="AMNEAL PHARMACEUTICALS, INC. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/AMRX/metrics/pe-ratio">AMNEAL PHARMACEUTICALS, INC. (AMRX) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	54.8×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	69.2×	703.82%
FY2020	8.6×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Sep 2026	38.2×	10.45%
Jun 2026	34.6×	8.62%
Mar 2026	31.9×	(41.82%)
Dec 2025	54.8×	(89.05%)
43 more quarters	Free account

Against its own ten years

Low 0.0× High 1,009×

Ten-year median 0.0×

Current reading's percentile 77

Company	P/E ratio
HIMS Hims & Hers Health, Inc. compare	n/m
ALKS Alkermes plc compare	n/m
ELAN Elanco Animal Health Incorporated compare	n/m
SUPN Indivior Pharmaceuticals Inc. compare	7.6×
LNTH Lantheus Holdings, Inc. compare	24.3×
LQDA Liquidia Corporation compare	28.5×
AMRX AMNEAL PHARMACEUTICALS, INC.	36.9×
RDY Dr. Reddy's Laboratories Ltd compare	44.4×
KNSA Kiniksa Pharmaceuticals International, plc compare	62.1×
Drug Manufacturers Specialty & Generic industry median	20.5×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

AMNEAL PHARMACEUTICALS, INC. (AMRX) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on AMRX

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on AMRX

Stockrow Weekly